TrialMolecular cancer therapeutics2015

Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team.

Patricia M LoRusso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.